A new biomarker-based risk score accurately predicts recurrent events in patients discharged after ACS and does so better than currently used risk-prediction tools, such as GRACE 2.0, according to a ...

For too long, financial advisors have been making asset allocation decisions for their clients according to a “risk score,” a figure developed around client questionnaires to determine how much risk ...

A risk-assessment tool incorporating NT-proBNP and high-sensitivity troponin performs better than clinical scores for predicting stroke among patients with atrial fibrillation (AF) who are taking oral ...

Researchers analyzed numerous biomarkers in patients at risk for inflammatory arthritis to develop measurable scores indicating a patient's vulnerability to disease progression. In a new study ...